2002•Arthritis & RheumatismRequires access

Successful rechallenge with anti–tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: Comment on the article by Mohan et al

Marcela Cisternas, Miguel Ángel Molina Gutiérrez, Sergio H. Jacobelli

Open publisher page 43 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Psoriatic arthritis, Disease, Demyelinating disease, Psoriasis, Multiple sclerosis, Tumor necrosis factor α, Tumor necrosis factor alpha

Back to paper search Browse research topics Original source

Successful rechallenge with anti–tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: Comment on the article by Mohan et al — Research Paper | ScholarLens